Kevin Tang, 10% Owner at Fulcrum Therapeutics, Inc. (FULC), bought 167,616 shares at $3.56 ($595K) on 2026-07-16, disclosed to the SEC on 2026-07-20.
Open-market purchase of $595k FULC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.56 | 116,671 | $415K | 69.8% |
| 2 | $3.52 | 50,945 | $179K | 30.2% |
| Total | $3.55 avg | 167,616 | $595K | 100% |
| Filing → |
| BOLD | BUY | 2026-07-16 | $156K | — | Filing → |
| FULC | BUY | 2026-07-15 | $891K | — | Filing → |
| BOLD | BUY | 2026-07-13 | $222K | — | Filing → |